Cargando…
BLV: lessons on vaccine development
Vaccination against retroviruses is a challenge because of their ability to stably integrate into the host genome, undergo long-term latency in a proportion of infected cells and thereby escape immune response. Since clearance of the virus is almost impossible once infection is established, the prim...
Autores principales: | Abdala, Alejandro, Alvarez, Irene, Brossel, Hélène, Calvinho, Luis, Carignano, Hugo, Franco, Lautaro, Gazon, Hélène, Gillissen, Christelle, Hamaidia, Malik, Hoyos, Clotilde, Jacques, Jean-Rock, Joris, Thomas, Laval, Florent, Petersen, Marcos, Porquet, Florent, Porta, Natalia, Ruiz, Vanesa, Safari, Roghaiyeh, Suárez Archilla, Guillermo, Trono, Karina, Willems, Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781361/ https://www.ncbi.nlm.nih.gov/pubmed/31590667 http://dx.doi.org/10.1186/s12977-019-0488-8 |
Ejemplares similares
-
How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?
por: Gazon, Hélène, et al.
Publicado: (2018) -
Recent Advances in BLV Research
por: Barez, Pierre-Yves, et al.
Publicado: (2015) -
Epidemiological features of BLV natural infection
por: Lomonaco, Marina, et al.
Publicado: (2014) -
Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma
por: Brossel, Hélène, et al.
Publicado: (2021) -
A safe and effective vaccine against bovine leukemia virus
por: Suárez Archilla, Guillermo, et al.
Publicado: (2022)